^
Association details:
Biomarker:TPM3-NTRK1 fusion
Cancer:Colorectal Cancer
Drug:GW441756 (TrkA receptor inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs

Published date:
11/10/2017
Excerpt:
Here, we present an in vivo imaging model for brain tumors using human cancer cell lines, including the EGFR-L858R/T790M-positive H1975 lung adenocarcinoma cells...KM12SM colorectal cancer cells containing the TPM3-NTRK1 gene fusion. In addition, KM12SM and KM12C cells displayed similar sensitivities to other MET inhibitors, such as golvatinib and GW441756.
DOI:
10.1002/cam4.1255